Immunoregulation of Thymosin α 1 Treatment of Cytomegalovirus Infection Accompanied With Acute Respiratory Distress Syndrome After Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 1, 2007, Pages 115-119

  Ji, S M ^a   Li, L S ^b   Sun, Q Q ^a   Chen, J S ^a   Sha, G Z ^a   Liu, Z H ^b  

^a Research Institute of Nephrology   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CREATININE; CYCLOSPORIN A; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOSIN ALPHA1; TUBERCULOSTATIC AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MYCOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, THORACIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; THYMOSIN;

EID: 33846599293     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.005     Document Type: Article

References (17)

1. Keay S. CMV infection and disease in kidney and pancreas transplant recipients. Transplant Infect Dis I 19 supp 1 (1999)
2. Morris D.J. Opportunities for diagnosis cytomegalovirus in pulmonary infection. Thorax 50 (1995) 3
3. Capulong M.G., Mendoza M., and Chavez J. Cytomegalovirus pneumonia in renal transplant patients. Transplant Proc 30 (1998) 3151
4. He X., and Li W. HPLC measure of thymosin α1 in Zadaxin. Guangdong Pharma 10 (2000) 22
5. Zhang Z., Li X., Jin Y., et al. In vitro experiments of Zadaxin induction of immunity-related cellular factors. Cancer Research and Clinic 14 (2002) 369
6. Zhen H., Shang J., Wang X., et al. Clinical evaluation of Zadaxin (thymosin α1) treatment of severe hepatitis. Chinese J Exp Clin Virol 14 (2000) 194
7. Li X., Wu G., Jin Y., et al. Zadaxin induction of tumor cell apoptosis. China Tumor Biotherapy 8 (2001) 280
8. Ljungman P., and Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S., and Plotkin S.A. (Eds). Multidisciplinary Approach to Understanding Cytomegalovirus Disease (1993), Elsevier Science Publisher BV, Paris 233
9. Qiu H., and Zhou Y. Modern therapy of multiple organ dysfunction syndrome (2001), People's Military Medicine Publisher, Beijing
10. Tao J., Ji D.-X., G-De-H, et al. Effects of continuous high volume hemofiltration in renal transplant recipients with severe pulmonary infection and acute respiratory distress syndrome. Chin J Nephrol Dialy Transplant 12 (2003) 240
11. Sun Q., Liu Z.-H., Chen J., et al. An aggressive systematic strategy for acute respiratory distress caused by severe pneumonia after renal transplantation. Transplant Int 19 (2006) 110
12. Sun Q., Li L., Ji S., et al. Variation of CD4+ and CD8+T lymphocytes as predictor of outcome in renal allograft recipients who developed acute respiratory distress syndrome caused by cytomegalovirus pneumonia. Transplant Proc 37 (2005) 2118
13. + detection and clinical significance. China Renal Diseases 12 (1996) 224
14. Sester M., Sester U., Gärtner B.C., et al. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J Am Soc Nephrol 13 (2002) 2577
15. Sester M., Sester U., Gärtner B.C., et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 71 (2001) 1287
16. Lu Z., Yao G., Wu X., et al. A comparative trial of thymosin α1 vs. thymosin α1 combined with interferon α1 b in the treatment of chronic hepatitis B. Chin J Infect Dis 17 (1999) 24
17. Wang Z. Yangjian: Immune regulation of Thymosin α1 was stutied in severe hepatitis. Traditional and Western Medicine Combined Treatment of Liver Diseases 9 (1999) 10